Retinal Diseases: all 817 studies

Page 2 of 9. Open to participants first (104), then studies with results posted, then the rest; newest registration first within each.

• National Eye Institute Biorepository for Retinal DiseasesRecruitingNCT01496625
• Cell Collection to Study Eye DiseasesRecruitingNCT01432847
• Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 GeneRecruitingNCT01145196
• Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural OutcomeRecruitingNCT00346814Phase 2/3
• Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)CompletedNCT06011798Phase 2Results posted
• Fundus Findings and Thiol-Disulfide HomeostaisCompletedNCT05958927Results posted
• Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular EdemaCompletedNCT05697809Phase 2Results posted
• Nesvategrast (OTT166) in Diabetic Retinopathy (DR)CompletedNCT05409235Phase 2Results posted
• Bangladesh PRODUCTIVity in Eyecare TrialCompletedNCT05182580Not applicableResults posted
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)TerminatedNCT05176717Phase 2/3Results posted
• Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)TerminatedNCT05158296Phase 2/3Results posted
• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)TerminatedNCT05066230Phase 3Results posted
• A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)TerminatedNCT05038020Phase 2Results posted
• A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser TreatmentCompletedNCT04919499Phase 1/2Results posted
• Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning ModelCompletedNCT04805541Results posted
• OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)TerminatedNCT04757636Phase 3Results posted
• Non-proliferative Diabetic Retinopathy Treated With RuncaciguatCompletedNCT04722991Phase 2Results posted
• A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular DegenerationTerminatedNCT04684394Phase 2Results posted
• Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationCompletedNCT04679935Phase 4Results posted
• Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Fundus ImagesCompletedNCT04612868Not applicableResults posted
• HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005TerminatedNCT04566445Phase 2Results posted
• A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator ArmCompletedNCT04503551Phase 3Results posted
• EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005TerminatedNCT04437368Phase 2Results posted
• HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular IschemiaCompletedNCT04424290Phase 1/2Results posted
• ADVM-022 Intravitreal Gene Therapy for DMECompletedNCT04418427Phase 2Results posted
• Agreement and Precision Study of the Nidek MiranteCompletedNCT04318132Not applicableResults posted
• A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic RetinopathyCompletedNCT04265261Phase 2Results posted
• A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee DR) for Screening of Diabetic Retinopathy in Patients With Diabetes MellitusCompletedNCT04160988Results posted
• Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of PrematurityCompletedNCT04101721Phase 3Results posted
• Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser TherapyCompletedNCT04004208Phase 3Results posted
• Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMDCompletedNCT03954626Phase 3Results posted
• Extension Study to Study PQ-110-001 (NCT03140969)TerminatedNCT03913130Phase 1/2Results posted
• FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMDTerminatedNCT03846193Phase 1/2Results posted
• Integrating DR Into Mainstream Health System in BangladeshCompletedNCT03658980Not applicableResults posted
• Lowering Events in Non-proliferative Retinopathy in ScotlandCompletedNCT03439345Phase 4Results posted
• Dyslipidemia and Diabetic RetinopathyCompletedNCT03403283Results posted
• PROMINENT-Eye Ancillary Study (Protocol AD)TerminatedNCT03345901Phase 3Results posted
• A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.CompletedNCT03238963Phase 2Results posted
• The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)CompletedNCT03197870Phase 2Results posted
• A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic RetinopathyCompletedNCT02963441Results posted
• Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic RetinopathyCompletedNCT02863354Phase 2Results posted
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDRCompletedNCT02858076Phase 2/3Results posted
• Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic RetinopathyCompletedNCT02834663Phase 4Results posted
• The EASE Study - Human Factor and Usability Testing of a Binocular OCT SystemCompletedNCT02822612Results posted
• Conbercept Injection in Treatment of Severe Proliferative Diabetic RetinopathyCompletedNCT02816710Phase 4Results posted
• Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic RetinopathyCompletedNCT02753400Phase 2Results posted
• Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)CompletedNCT02718326Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDRTerminatedNCT02681809Phase 2Results posted
• Rainbow Extension StudyCompletedNCT02640664Phase 3Results posted
• Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or BevacizumabCompletedNCT02559180Phase 4Results posted
• SD-OCT AngiographyTerminatedNCT02510885Not applicableResults posted
• Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of PrematurityCompletedNCT02486042Phase 2Results posted
• Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of PrematurityCompletedNCT02390531Phase 1Results posted
• Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)CompletedNCT02386839Phase 2Results posted
• RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of PrematurityCompletedNCT02375971Phase 3Results posted
• X-82 to Treat Age-related Macular DegenerationTerminatedNCT02348359Phase 2Results posted
• Assessment of Novel Intraocular Injection GuideCompletedNCT02315170Not applicableResults posted
• Clinical Study of the Optic Disc ParametersCompletedNCT02277119Not applicableResults posted
• Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.CompletedNCT02222610Phase 2Results posted
• Aflibercept After Ranibizumab in Exudative Age-related Macular DegenerationCompletedNCT02157077Phase 3Results posted
• Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract SurgeryCompletedNCT01988246Phase 1/2Results posted
• Inositol to Reduce Retinopathy of PrematurityTerminatedNCT01954082Phase 3Results posted
• RETeval Study for Diabetic RetinopathyCompletedNCT01950663Not applicableResults posted
• OCT Screening for Diabetic Macular Edema at Primary Diabetes Care VisitsCompletedNCT01875783Not applicableResults posted
• The Influence of Fish-oil Lipid Emulsions on Neonatal MorbiditiesCompletedNCT01875510Not applicableResults posted
• Nepafenac Once Daily for Macular Edema - Study 2CompletedNCT01872611Phase 3Results posted
• Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic RetinopathyCompletedNCT01854593Phase 4Results posted
• Nepafenac Once Daily for Macular Edema - Study 1CompletedNCT01853072Phase 3Results posted
• Aflibercept Injection for Proliferative Diabetic RetinopathyCompletedNCT01805297Phase 2Results posted
• Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLOCompletedNCT01692938Results posted
• Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)CompletedNCT01594281Phase 2Results posted
• Finasteride for Chronic Central Serous ChorioretinopathyTerminatedNCT01585441Phase 2Results posted
• Ozurdex for Treatment of Recalcitrant Diabetic Macular EdemaCompletedNCT01571232Phase 2Results posted
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic RetinopathyCompletedNCT01489189Phase 3Results posted
• Trial of Subretinal Injection of (rAAV2-VMD2-hMERTK)CompletedNCT01482195Phase 1Results posted
• Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal MelanomaTerminatedNCT01471054Phase 2Results posted
• Topical Interferon Gamma-1b for Central Serous ChorioretinopathyCompletedNCT01468337Phase 1/2Results posted
• Avastin for PDR (Proliferative Diabetic Retinopathy)CompletedNCT01270542Not applicableResults posted
• Proparacaine and Mydriatic Eye DropsTerminatedNCT01266824Not applicableResults posted
• Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective StudyCompletedNCT01238471Phase 1/2Results posted
• Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT01227993Phase 1/2Results posted
• Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)TerminatedNCT01225146Phase 1Results posted
• High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal TelangiectasiaCompletedNCT01205035Phase 2Results posted
• A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular EdemaCompletedNCT01100307Phase 3Results posted
• IGF-1/IGFBP3 Prevention of Retinopathy of PrematurityCompletedNCT01096784Phase 2Results posted
• Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract SurgeryCompletedNCT01069341Phase 1Results posted
• INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMDCompletedNCT01016873Phase 2Results posted
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)CompletedNCT00996437Phase 2/3Results posted
• Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic RetinopathyCompletedNCT00917553Phase 2Results posted
• Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT00837252Phase 1/2Results posted
• Topcon 3D OCT-1000 Optical Coherence Tomography SystemCompletedNCT00792259Results posted
• A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy PatientsCompletedNCT00782717Phase 2Results posted
• Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic VitrectomyCompletedNCT00745498Not applicableResults posted
• Sirolimus to Treat Diabetic Macular EdemaCompletedNCT00711490Phase 1/2Results posted
• Evaluation of Vitrectomy for Diabetic Macular EdemaCompletedNCT00709319Results posted
• Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)TerminatedNCT00668785Phase 2Results posted
• Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in PrematurityTerminatedNCT00634972Phase 4Results posted
• Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of PrematurityStatus unknownNCT00622726Phase 2Results posted
• Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 StudyCompletedNCT00604383Phase 3Results posted
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal DetachmentCompletedNCT00548197Phase 1Results posted

← Retinal Diseases overview